Ana Rilak Simović (Ana Rilak Simovic)

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2020-2023
Publications (10 Years): 6

Top Topics

Capillary Electrophoresis

Human Serum Albumin

Molecular Docking

Top Venues

Dalton transactions (Cambridge, England : 2003)

Molecules (Basel, Switzerland)

This page only lists publications with an associated author ORCID identifier.

Publications

Milica Međedović, Ana Rilak Simović, Dušan Ćoćić, Laura Senft, Sanja Matić, Danijela Todorović, Suzana Popović, Dejan Baskić, Biljana Petrović
New ruthenium(II) complexes with quinone diimine and substituted bipyridine as inert ligands: synthesis, characterization, mechanism of action, DNA/HSA binding affinity and cytotoxic activity. Dalton transactions (Cambridge, England : 2003) (2023)
Milica Međedović, Ana Rilak Simović, Dušan Ćoćić, Laura Senft, Sanja Matić, Danijela Todorović, Suzana Popović, Dejan Baskić, Biljana Petrović
New ruthenium(II) complexes with quinone diimine and substituted bipyridine as inert ligands: synthesis, characterization, mechanism of action, DNA/HSA binding affinity and cytotoxic activity. Dalton transactions (Cambridge, England : 2003) 52 (5) (2023)
Milica Međedović, Ana Rilak Simović, Dušan Ćoćić, Laura Senft, Sanja Matić, Danijela Todorović, Suzana Popović, Dejan Baskić, Biljana Petrović
New ruthenium(II) complexes with quinone diimine and substituted bipyridine as inert ligands: synthesis, characterization, mechanism of action, DNA/HSA binding affinity and cytotoxic activity. Dalton transactions (Cambridge, England : 2003) 52 (5) (2023)
Milica Međedović, Ana Rilak Simović, Dušan Ćoćić, Laura Senft, Sanja Matić, Danijela Todorović, Suzana Popović, Dejan Baskić, Biljana Petrović
New ruthenium(II) complexes with quinone diimine and substituted bipyridine as inert ligands: synthesis, characterization, mechanism of action, DNA/HSA binding affinity and cytotoxic activity. Dalton transactions (Cambridge, England : 2003) 52 (5) (2023)
Dejan Lazić, Andreas Scheurer, Dušan Ćoćić, Jelena Milovanović, Aleksandar Arsenijević, Bojana Stojanović, Nebojša Arsenijević, Marija Milovanović, Ana Rilak Simović
A new bis-pyrazolylpyridine ruthenium(III) complex as a potential anticancer drug: in vitro and in vivo activity in murine colon cancer. Dalton transactions (Cambridge, England : 2003) 50 (22) (2021)
Maja Savic, Aleksandar Arsenijevic, Jelena Milovanovic, Bojana Stojanovic, Vesna Stankovic, Ana Rilak Simović, Dejan Lazic, Nebojsa Arsenijevic, Marija Milovanovic
Antitumor Activity of Ruthenium(II) Terpyridine Complexes towards Colon Cancer Cells In Vitro and In Vivo. Molecules (Basel, Switzerland) 25 (20) (2020)